Trial Profile
Sirolimus- vs paclitaxel-eluting stent for the prevention of restenosis in haemodialysis patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2013
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 21 Aug 2013 New trial record